BioSpace News Archive

Business

Jennifer Doudna’s Second Act: COVID-19 and Beyond

Doudna, the subject of a new book by Walter Isaacson titled “The Code Breaker: Jennifer Doudna, Gene Editing, and the Future of the Human Race,” has kept busy.

March 10, 2021
·
3 min read
·
Mark Terry
Drug Development

Machine Learning Model Predicts Innovation’s Brilacidin Highly Effective Against COVID-19

A machine learning model that screened 1,482 compounds potentially effective for treating coronavirus disease 2019 (COVID-19) has ranked Innovation Pharma’s COVID-19 candidate brilacidin in the top 3% of compounds predicted to be most effective against the novel coronavirus.

March 10, 2021
·
3 min read
·
Brandon May
Genetown

Quench Bio Winds Down Operations Following ‘Successful Failure’

A little more than a year after securing $50 million in a Series A financing round, Quench Bio, an Atlas Venture company, is shutting down operations after failing to meet its therapeutic goals.

March 10, 2021
·
2 min read
·
Alex Keown
Drug Development

Analyses Show bluebird’s LentiGlobin Unlikely Cause of Leukemia in Trial Patient

Preliminary findings of LentiGlobin suggested that the BB305 LVV vector was present in the AML blast cells, but there was not sufficient information to determine causality.

March 10, 2021
·
3 min read
·
Alex Keown
Deals

Are SPACs Better Than Traditional IPOs?

Here’s the scoop on IPO versus SPAC (Special Purpose Acquisition Corporation) from Paul Mieyal, life sciences investment guru.

March 10, 2021
·
4 min read
·
Kate Goodwin
Policy

FDA Update: Former Commissioners Urge Permanent Nomination and More

With no permanent commissioner, the U.S. Food and Drug Administration appears to be both cracking down on Accelerated Approvals while struggling with a backlog of inspections.

March 10, 2021
·
4 min read
·
Mark Terry
2020 Tailwinds Usher in a Post-Pandemic Biotech Revolution

Cooperation and collaboration accelerated drug development timelines during the pandemic, and those gains are expected to continue into the coming years. Innovation is increasing too, as new tools are developed.

March 10, 2021
·
4 min read
·
Gail Dutton
Job Trends

Lilly’s Antibody Combo Reduces Death, Hospitalization in Early COVID-19

Bamlanivimab is a product born from a collaboration between Lilly and AbCellera, with Lilly reportedly developing the therapy in under three months following discovery by AbCellera.

March 10, 2021
·
3 min read
·
Brandon May
BioSpace Global Roundup, March 11

Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.

March 10, 2021
·
9 min read
·
Alex Keown
Business

GSK CEO Takes Financial Hit After Company Fails to Meet Internal Goal

GlaxoSmithKline failed to hit a key internal profit goal in 2020, due in large part to the impact of the COVID-19 pandemic. As a result, Chief Executive Officer Emma Walmsley took a nearly $2 million hit to her annual compensation.

March 10, 2021
·
2 min read
·
Alex Keown